Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Masana

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2017
Results of the REVEAL study. Why Should we not welcome a new lipid lowering agent?Luis Masana
Revista Espanola De Cardiologia (English Ed.)|May 15, 2017
The Zero-LDL Hypothesis. Towards Extremely Low LDL ConcentrationsLuis Masana
Cardiovascular Diabetology|July 4, 2013
Pitavastatin in cardiometabolic disease: therapeutic profileLuis Masana
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 25, 2019
Treating dyslipidemia: something more than giving statinsLuis Masana
Medicina Clinica|May 26, 2007
[Serum markers of coronary atherosclerosis]Luis Masana Marín
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
[Unmet needs: patients with statin intolerance or familial hypercholesterolemia]Luis Masana, Fernando Civeira
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 14, 2015
[Update of planning tables of cholesterol-lowering therapy orientated to achieve LDL therapeutic targets]Luis Masana, Núria Plana
Journal of Medical Genetics|March 17, 2019
Review of the scientific evolution of gene therapy for the treatment of homozygous familial hypercholesterolaemia: past, present and future perspectivesRicardo Rodriguez-Calvo, Luis Masana
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 3, 2014
The pleiotropic role of HDL in autoimmune diseasesSandra Parra, Antoni Castro, Luis Masana
Atherosclerosis|October 30, 2016
Dose wisely! How lipid-lowering undertreatment can lead to overtreatmentLuis Masana, Jeanine Roeters van Lennep
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2017
Results of the REVEAL study. Why Should we not welcome a new lipid lowering agent?Luis Masana
Revista Espanola De Cardiologia (English Ed.)|May 15, 2017
The Zero-LDL Hypothesis. Towards Extremely Low LDL ConcentrationsLuis Masana
Cardiovascular Diabetology|July 4, 2013
Pitavastatin in cardiometabolic disease: therapeutic profileLuis Masana
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 25, 2019
Treating dyslipidemia: something more than giving statinsLuis Masana
Medicina Clinica|May 26, 2007
[Serum markers of coronary atherosclerosis]Luis Masana Marín
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
[Unmet needs: patients with statin intolerance or familial hypercholesterolemia]Luis Masana, Fernando Civeira
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 14, 2015
[Update of planning tables of cholesterol-lowering therapy orientated to achieve LDL therapeutic targets]Luis Masana, Núria Plana
Journal of Medical Genetics|March 17, 2019
Review of the scientific evolution of gene therapy for the treatment of homozygous familial hypercholesterolaemia: past, present and future perspectivesRicardo Rodriguez-Calvo, Luis Masana
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 3, 2014
The pleiotropic role of HDL in autoimmune diseasesSandra Parra, Antoni Castro, Luis Masana
Atherosclerosis|October 30, 2016
Dose wisely! How lipid-lowering undertreatment can lead to overtreatmentLuis Masana, Jeanine Roeters van Lennep
Pageof 12